4Wolfe RA,Ashby VB,Milford EL,et al.Comparison of mortality in all patients on dialysis,patients on dialysis awaiting transplantation,and recipients of a first cadaveric transplant.N Engl J Med,1999,341:1725.
5Timothy H.Mathew.A Blinded,Long-team,Randomized Multicenter Study of Mycophenolate Mofetil in Cadaveric Renal transplantation.Transplantation,1998,65:1450-1454.
6Hariharan S,Johnson CP,Bresnahan BA,et al.Improved graft survival after renal transplantation in the United States,1988 to 1996.N Engl J med,2000,342:1837-1838.
7Wuthrich RP,Weinreich T,et al.Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.Nephrol-Dial-Transplant,1999,14:394-399.
8Garcia DM,O'Valle F,Andluar M,et al.Relationship between P-glycoprotein expression and cyclosporine A in kidney:An immunohistological and cell culture study.Am J Pathol 1995;146:398-408
10Ingerborg AH,Michael K,Ulrich H,et al.Therapeutic concentrations of cyclosporine A,but not FK506,increase P-glycoprotein expression in endothelial and renal tubule cells.Kid Int 1998;54(4):1139-1149
